Open AccessIdentification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy
Author(s) -
Long Junyu,
Yang Xu,
Bian Jin,
Wang Dongxu,
Wang Anqiang,
Lin Yu,
Zheng Mingjun,
Zhang Haohai,
Sang Xinting,
Zhao Haitao
Publication year - 2021
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.598
Subject(s) - toxicity , medicine , cd8 , pd l1 , mutation , identification (biology) , pharmacology , oncology , genetics , immunotherapy , immune system , immunology , biology , gene , cancer , botany